Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate

CAS : 65906-75-4

Ref. 3D-FE98042

Informations sur le produit

• Nom: Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate

Description

Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate is a drug that has been used in clinical studies for the treatment of primary brain tumors. It has shown clinical response rates of up to 87%, with the most favourable response observed in patients with low tumor grade and well differentiated histology. The drug is administered orally and penetrates tissues, including the central nervous system. Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5 carboxylate has been found to be toxic to ameloblasts and cancer cells in vitro. Tumor regression was observed in animals treated with ethyl 4 butoxy 5 fluoro 2 6 dioxohexahydropyrimidine 5 carboxylate, which led to decreased symptoms such as weight loss and cachexia.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 276.26 g/mol
• Formule: C₁₁H₁₇FN₂O₅
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C11H17FN2O5/c1-3-5-6-19-8-11(12,9(16)18-4-2)7(15)13-10(17)14-8/h8H,3-6H2,1-2H3,(H2,13,14,15,17)
• Code InChI: InChIKey=QYIJQWZDUJULHZ-UHFFFAOYSA-N
• SMILES: CCCCOC1NC(=O)NC(=O)C1(F)C(=O)OCC